Literature DB >> 24175222

Hepatitis viruses and non-Hodgkin's lymphoma: A review.

Sibnarayan Datta1, Soumya Chatterjee, Rudragoud S Policegoudra, Hemant K Gogoi, Lokendra Singh.   

Abstract

Non-Hodgkin's lymphoma (NHL) is among the haematological malignancies with high prevalence worldwide, causing estimated 355 900 new cases and 191 400 deaths in 2008. High prevalence of NHL is documented in economically more developed areas while low prevalence is observed in less developed areas of the globe. A wide array of environmental factors have been reported to be either directly involved or in modifying the risk of NHL development. In addition to these factors, a number of infectious agents, chiefly viruses have also been implicated in the development of NHL. This article reviews the available literature to discuss the role of hepatitis viruses in NHL development, possible mechanisms of lymphomagenesis and also identify the areas in which further research is required to better understand this disease. A brief discussion on the clinical aspects such as classification, staging, treatment approaches have also been included in this article.

Entities:  

Keywords:  Hepatitis B virus; Hepatitis C virus; Hepatitis G virus; MiRNA; Non-Hodgkin’s lymphoma

Year:  2012        PMID: 24175222      PMCID: PMC3782277          DOI: 10.5501/wjv.v1.i6.162

Source DB:  PubMed          Journal:  World J Virol        ISSN: 2220-3249


  136 in total

Review 1.  Molecular diagnostic approach to non-Hodgkin's lymphoma.

Authors:  D A Arber
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

Review 2.  Viruses, microRNAs, and host interactions.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

3.  Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.

Authors:  M Kuniyoshi; M Nakamuta; H Sakai; M Enjoji; N Kinukawa; K Kotoh; M Fukutomi; M Yokota; H Nishi; H Iwamoto; N Uike; J Nishimura; S Inaba; Y Maeda; H Nawata; K Muta
Journal:  J Gastroenterol Hepatol       Date:  2001-02       Impact factor: 4.029

Review 4.  Non-Hodgkin's lymphomas: current classification and management.

Authors:  A T Skarin; D M Dorfman
Journal:  CA Cancer J Clin       Date:  1997 Nov-Dec       Impact factor: 508.702

5.  Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process.

Authors:  V De Re; S De Vita; A Marzotto; A Gloghini; B Pivetta; D Gasparotto; R Cannizzaro; A Carbone; M Boiocchi
Journal:  Int J Cancer       Date:  2000-07-15       Impact factor: 7.396

Review 6.  Viruses in human cancers.

Authors:  H zur Hausen
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

7.  Hepatitis B virus infection associated with hematopoietic tumors.

Authors:  E Galun; Y Ilan; N Livni; M Ketzinel; O Nahor; G Pizov; A Nagler; A Eid; A Rivkind; M Laster
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

Review 8.  Pesticides and non-Hodgkin's lymphoma.

Authors:  S H Zahm; A Blair
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

9.  Interferon modulation of cellular microRNAs as an antiviral mechanism.

Authors:  Irene M Pedersen; Guofeng Cheng; Stefan Wieland; Stefano Volinia; Carlo M Croce; Francis V Chisari; Michael David
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

10.  Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems.

Authors:  Poornima Parameswaran; Ella Sklan; Courtney Wilkins; Trever Burgon; Melanie A Samuel; Rui Lu; K Mark Ansel; Vigo Heissmeyer; Shirit Einav; William Jackson; Tammy Doukas; Suman Paranjape; Charlotta Polacek; Flavia Barreto dos Santos; Roxana Jalili; Farbod Babrzadeh; Baback Gharizadeh; Dirk Grimm; Mark Kay; Satoshi Koike; Peter Sarnow; Mostafa Ronaghi; Shou-Wei Ding; Eva Harris; Marie Chow; Michael S Diamond; Karla Kirkegaard; Jeffrey S Glenn; Andrew Z Fire
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

View more
  8 in total

Review 1.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  Primary lymphoma of the gallbladder accompanied by cirrhosis: CT and MRI findings.

Authors:  Abdussamed Batur; Kemal Odev
Journal:  BMJ Case Rep       Date:  2014-05-14

Review 3.  Optimizing antiviral agents for hepatitis B management in malignant lymphomas.

Authors:  Oluwatobi O Ozoya; Julio Chavez; Lubomir Sokol; Samir Dalia
Journal:  Ann Transl Med       Date:  2017-02

Review 4.  Hepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention Strategies.

Authors:  Oluwatobi O Ozoya; Lubomir Sokol; Samir Dalia
Journal:  J Clin Transl Hepatol       Date:  2016-06-15

5.  Risk of Non-Hodgkin Lymphoma among Patients with Hepatitis B Virus and Hepatitis C Virus in Taiwan: A Nationwide Cohort Study.

Authors:  Yung-Rung Lai; Ya-Lan Chang; Chiu-Hsiang Lee; Tung-Han Tsai; Kuang-Hua Huang; Chien-Ying Lee
Journal:  Cancers (Basel)       Date:  2022-01-24       Impact factor: 6.639

Review 6.  Virus-Driven Carcinogenesis.

Authors:  Yuichiro Hatano; Takayasu Ideta; Akihiro Hirata; Kayoko Hatano; Hiroyuki Tomita; Hideshi Okada; Masahito Shimizu; Takuji Tanaka; Akira Hara
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

7.  Plasma Epstein-Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses.

Authors:  Mahua Sinha; Clementina Rama Rao; C S Premalata; Mohammed Shafiulla; K C Lakshmaiah; Linu Abraham Jacob; Govind K Babu; B K Viveka; L Appaji; Jayshree R Subramanyam
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Jul-Sep

8.  Occult hepatitis C virus infection in patients with malignant lymphoproliferative disorders.

Authors:  Abeya A Lotfi; Asmaa E Mohamed; Nahela A Shalaby; Deena S Eissa; Ehab El-Dabaa; Ayman M Sallam; Mahmoud M Kamel; Hisham Abdelaziz; Amal M El-Afifi; Ahmed S Abdel-Moneim
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.